Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBKIR.L Regulatory News (BKIR)

  • There is currently no data for BKIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Participation in NAMA

19 Jul 2010 16:27

RNS Number : 5754P
Bank of Ireland(Governor&Co)
19 July 2010
 



NAMA19 July 2010

 

Update on Bank of Ireland Group's Participation in the National Asset Management Agency ("NAMA")

 

Bank of Ireland Group has completed and submitted to NAMA all of the due diligence material in respect of its Tranche 2 loans and associated derivatives amounting to €2.3bn in nominal value. These loans comprise €1.1bn of land and development loans and €1.2bn of associated loans. The nominal value of the consideration to be received for these loans is expected to be approximately €1.5bn resulting in an estimated discount to gross book value (before impairment provisions) on these loans of approximately 34.9%.

 

As at 19 July 2010, Bank of Ireland Group has transferred €1.8bn (before impairment provisions) of these Tranche 2 loans to NAMA, comprising €1.0bn land and development loans and €0.8bn associated loans. The nominal value of the consideration received for these loans transferred amounted to €1.1bn in Government guaranteed bonds and non-guaranteed subordinated bonds resulting in a gross loss on book value of approximately €0.7bn1 and an estimated discount to gross book value on these loans of approximately 38.5%. The remaining Tranche 2 loans, which predominantly comprise associated loans, are expected to transfer to NAMA in due course.

 

As previously advised, the gross loss on disposal of Bank of Ireland Group Eligible Bank Assets to NAMA will be a function of three factors: the quantum of those loans, the mix of those loans, as between land and development and associated loans, and the discount that would apply to those loans. The Group announced on 26 April 2010 that it believed that the discount on the total portfolio of €12.2bn expected to transfer to NAMA would be within the guidance of €4.8bn (before impairment provisions of €2.8bn at 31 December 2009) provided at the Extraordinary General Court of the Bank on 12 January 2010. The Group made this statement on the basis of the discount arising on Tranche 1 coupled with the results of a valuation exercise on a sample of €6.0bn (approximately 50% of the loans which the Group expects to transfer to NAMA). On the basis of the results of Tranche 1 and the anticipated results of Tranche 2 outlined above, the Group does not expect any material difference to the position announced on 26 April 2010.

 

However, as previously advised, significant uncertainties still remain as to the final discount which will be applicable to Bank of Ireland Group. The Group will only be able to accurately quantify the ultimate gross loss on the transfer of all the Bank of Ireland Eligible Bank Assets to NAMA on completion of the relevant due diligence and the transfer of all the loans to NAMA.

 

1 Prior to (i) any impairment previously recognised by the Group, (ii) the fair value adjustments in respect of any consideration received, (iii) any provision that may be required under accounting standards due to the ongoing cost of servicing these assets on behalf of NAMA, and (iv) taking account of the costs of the transfer.

 

For further information, please contact:

John O'Donovan

Group Chief Financial Officer

+353 (0) 76 623 4703

Andrew Keating

Director of Group Finance

+353 (0) 1 637 8141

Dan Loughrey

Head of Group Corporate Communications

+353 (0) 76 623 4770

 

 

Forward Looking Statement

This document contains certain forward looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934 and Section 27A of the US Securities Act of 1933 with respect to certain of the Bank of Ireland Group's (the Group) plans and its current goals and expectations relating to its future financial condition and performance and the markets in which it operates. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', or other words of similar meaning. Examples of forward looking statements include among others, statements regarding the Group's future financial position, income growth, business strategy, projected costs, projected impairment losses, capital ratios, margins, future payment of dividends, the outcome of the current review of the Group's defined benefit pension schemes, estimates of capital expenditures, discussions with Irish, European and other regulators and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, risks and uncertainties relating to the performance of the Irish and UK economies, property market conditions in Ireland and the UK, costs of funding, the performance and volatility of international capital markets, the expected level of credit defaults, the impact of the National Asset Management Agency, the Group's ability to expand certain of its activities, development and implementation of the Group's strategy, including the ability to achieve estimated cost reductions, competition, the Group's ability to address information technology issues, and the availability of funding sources. Any forward looking statements speak only as at the date they are made. The Group does not undertake to release publicly any revision to these forward looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. The reader should however, consult any additional disclosures that the Group has made or may make in documents filed or submitted or may file or submit to the US Securities and Exchange Commission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKUVRROABAAR
Date   Source Headline
10th Mar 20143:39 pmRNSAnnual Financial Report
6th Mar 20145:15 pmRNSDirector/PDMR Shareholding
6th Mar 20145:15 pmRNSNotification of Significant Shareholding
6th Mar 20145:15 pmRNSNotification of Significant Shareholding
3rd Mar 20144:30 pmRNSNotification of Significant Shareholding
3rd Mar 20143:23 pmRNSBank of Ireland Mortgage Bank 2013 Accounts
3rd Mar 20147:00 amRNSPreliminary Statement
28th Feb 201411:03 amRNSNotification of Significant Shareholding
26th Feb 20144:38 pmRNSNotification of Significant Shareholding
13th Feb 20144:56 pmRNSNotification of Significant Shareholding
29th Jan 20144:31 pmRNSNotification of Significant Shareholding
27th Jan 201412:16 pmRNSNotification of Significant Shareholding
22nd Jan 201412:49 pmRNSNotification of Significant Shareholding
8th Jan 20148:25 amRNSStabilisation Notice Bank of Ireland 5year
7th Jan 20142:18 pmRNSNotification of Significant Shareholding
3rd Jan 20142:49 pmRNSBlocklisting Interim Review
31st Dec 201312:22 pmRNSTotal Voting Rights
16th Dec 20136:27 pmRNS2013 EBA EU-Wide Disclosure Exercise
13th Dec 201311:13 amRNSNotification of Significant Shareholding
12th Dec 201312:25 pmRNSNotification of Significant Shareholding
11th Dec 20138:13 amRNSTotal Voting Rights
9th Dec 20134:05 pmRNSTotal Voting Rights
9th Dec 20139:18 amRNSTotal Voting Rights
9th Dec 20138:00 amRNSMain Securities Market Notice
4th Dec 20136:11 pmRNSCapital Package Sale of 2009 Prefs
4th Dec 20133:19 pmRNSResults of Placing
4th Dec 20138:20 amRNSPre-Stabilisation Notice Bank of Ireland Notes
4th Dec 20137:06 amRNS2009 Prefs Sale and Ordinary Stock Placing
2nd Dec 20137:18 amRNSAsset Quality Review
26th Nov 20135:11 pmRNS2009 Preference Shares
26th Nov 201311:30 amRNSNotification of Significant Shareholding
5th Nov 20134:00 pmRNSNotification of Significant Shareholding
4th Nov 20132:15 pmRNSNotification of Significant Shareholding
1st Nov 20132:45 pmRNSInterim Management Statement
23rd Oct 201312:14 pmRNSUpdate on Pension Review
13th Sep 20133:10 pmRNSNotification of Significant Shareholding
20th Aug 20135:00 pmRNSNotification of Significant Shareholding
12th Aug 201311:56 amRNSDirector/PDMR Shareholding
7th Aug 20139:43 amRNSDirector/PDMR Shareholding
2nd Aug 20137:00 amRNSInterim Report 30 June 2013
23rd Jul 20134:07 pmRNSDirectorate Change
19th Jul 20132:49 pmRNSMelepard CDO 1 Limited
9th Jul 201310:54 amRNSEU Restructuring Plan Update
3rd Jul 20134:22 pmRNSBlocklisting Interim Review
25th Jun 20132:18 pmRNSDirector/PDMR Shareholding
20th Jun 201310:58 amRNSEarly Redemption Notice
11th Jun 201312:47 pmRNSRepurchase Confirmation
28th May 20132:15 pmRNSRepurchase Confirmation
21st May 20134:36 pmRNSRepurchase Confirmation
24th Apr 20134:29 pmRNSNotice of Results of Annual General Court

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.